Impact of Reduction in Myeloid‐derived Suppressor Cells by Wilms’ Tumor 1‐targeted Dendritic Cell Vaccines on Clinical Outcomes in Acute Leukemia Patients

Impact of Reduction in Myeloid‐derived Suppressor Cells by Wilms’ Tumor 1‐targeted Dendritic Cell Vaccines on Clinical Outcomes in Acute Leukemia Patients

ABSTRACT Background Myeloid‐derived suppressor cells (MDSCs) play a critical role in immunotherapy. Methods We investigated the effects of the Wilms' tumor 1 (WT1) peptide‐loaded dendritic cell (DC) vaccination on MDSCs in patients with acute leukemia. Results WT1‐DC vaccination reduced MDSCs a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Masahiro Ogasawara, Mamiko Miyashita, Yuka Yamagishi, Shuichi Ota
Format:	Article
Language:	English
Published:	Wiley 2025-06-01
Series:	eJHaem
Subjects:	acute leukemia dendritic cell vaccine myeloid‐derived suppressor cells Wilms' tumor 1
Online Access:	https://doi.org/10.1002/jha2.70048
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Myeloid-Derived Suppressor Cells in Some Oncohematological Diseases
by: AV Ponomarev
Published: (2017-01-01)

Immunosuppressive role of CD11b+CD33+HLA‐DR− myeloid‐derived suppressor cells‐like blast subpopulation in acute myeloid leukemia
by: Shin Young Hyun, et al.
Published: (2020-10-01)

The role of myeloid-derived suppressor cells in children
by: Jordan Brauner, et al.
Published: (2025-02-01)

Myeloid-derived suppressor cells in secondary sepsis: Is there an association with lethal outcome?
by: Udovičić Ivo, et al.
Published: (2020-01-01)

The Wilms’ Tumor Suppressor WT1 in Cardiomyocytes: Implications for Cardiac Homeostasis and Repair
by: Sandra Díaz del Moral, et al.
Published: (2024-12-01)

Immunosuppressive cells in acute myeloid leukemia: mechanisms and therapeutic target
by: Mengnan Liu, et al.
Published: (2025-07-01)

Wilms’ tumor 1 -targeting cancer vaccine: Recent advancements and future perspectives
by: Masahiro Ogasawara
Published: (2024-12-01)

Aging modulates the immunosuppressive, polarizing and metabolic functions of blood-derived myeloid-derived suppressor cells (MDSCs)
by: Emma Keltsch, et al.
Published: (2025-07-01)

The Recruitment and Immune Suppression Mechanisms of Myeloid‐Derived Suppressor Cells and Their Impact on Bone Metastatic Cancer
by: Chengyuan Li, et al.
Published: (2025-02-01)

The role of myeloid-derived suppressor cells in the pathogenesis of rheumatoid arthritis; anti- or pro-inflammatory cells?
by: Misagh Rajabinejad, et al.
Published: (2019-12-01)

The effect of conditioned media on the cellular proliferation of pancreatic cancer cells, pancreatic stellate cells, and myeloid-derived suppressor cells
by: Y. Chong, et al.
Published: (2025-01-01)

Myeloid-Derived Suppressor Cells in Bladder Cancer: An Emerging Target
by: Clément Klein, et al.
Published: (2024-10-01)

Myeloid-derived suppressor-like cells - does their frequency change in patients with different stages of CRC?
by: Brčerević Irina, et al.
Published: (2023-01-01)

Abnormal proportions and functions of myeloid-derived suppressor cells in peripheral blood of patients with diffuse large B-cell lymphoma
by: Jingru Liu, et al.
Published: (2025-04-01)

Sorafenib enhanced the function of myeloid-derived suppressor cells in hepatocellular carcinoma by facilitating PPARα-mediated fatty acid oxidation
by: Chunxiao Li, et al.
Published: (2025-01-01)

Th17/Treg balance is regulated by myeloid‐derived suppressor cells in experimental autoimmune myocarditis
by: Xin Xiong, et al.
Published: (2023-06-01)

Recruitment of Polymorphonuclear Myeloid-Derived Suppressor Cells During Cryptococcus neoformans Infection
by: JOYCE C. GUIMARÃES-DE-OLIVEIRA, et al.
Published: (2025-04-01)

Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invigorate antitumor immunity in pancreatic cancer
by: Nilesh U. Deshpande, et al.
Published: (2025-06-01)

Myeloid-derived suppressor cells in multiple myeloma patients at the immune recovery and after high-dose chemotherapy and hematopoietic stem cell transplantation
by: T. V. Tyrinova, et al.
Published: (2023-01-01)

A novel method for isolation of tumor infiltrating myeloid-derived suppressor cells from human lung tumor tissue
by: Marta Piqueras-Nebot, et al.
Published: (2025-04-01)

Pre-treatment monocytic myeloid-derived suppressor cells as predictive biomarkers for immune checkpoint inhibitor response in clear cell renal cell carcinoma
by: Yiming Jin, et al.
Published: (2025-08-01)

MiR‐486 promotes proliferation and suppresses apoptosis in myeloid cells by targeting Cebpa in vitro
by: Jingwei Jiang, et al.
Published: (2018-09-01)

Association of myeloid-derived suppressor cells with hematopoietic recovery after high-dose chemotherapy in multiple myeloma
by: V. S. Anmut, et al.
Published: (2023-06-01)

High Humidity Alters Myeloid-Derived Suppressor Cells in Spleen Tissue: Insights into Rheumatoid Arthritis Progression
by: Wang H, et al.
Published: (2024-11-01)

Caspase‐6/Gasdermin C‐Mediated Tumor Cell Pyroptosis Promotes Colorectal Cancer Progression Through CXCL2‐Dependent Recruitment of Myeloid‐Derived Suppressor Cells
by: Hanchao Gao, et al.
Published: (2025-05-01)

PKN2 enhances the immunosuppressive activity of polymorphonuclear myeloid-derived suppressor cells in esophageal carcinoma by mediating fatty acid oxidation
by: Xiao Fu, et al.
Published: (2025-03-01)

Myeloid-derived suppressor cells in axial spondyloarthritis patients with different types of therapy
by: A. Yu. Morenkova, et al.
Published: (2024-06-01)

Myeloid dendritic cells and periodontal disease association: integrated study of single-cell sequencing and Mendelian randomization analysis
by: ChengJi Shi, et al.
Published: (2025-01-01)

HDAC1-3 inhibition triggers NEDD4-mediated CCR2 downregulation and attenuates immunosuppression in myeloid-derived suppressor cells
by: Zhiqi Xie, et al.
Published: (2025-02-01)

Myeloid dendritic cells in peripheral blood correlate with the occurrence of acute graft-versus-host disease
by: Qianqian Wang, et al.
Published: (2025-07-01)

Do nature of bacteremia and origin of secondary sepsis in critically ill patients determine subset of myeloid-derived suppressor cells expansion?
by: Udovičić Ivo, et al.
Published: (2020-01-01)

Etomoxir Sodium Salt Promotes Imidazole Ketone Erastin-Induced Myeloid-Derived Suppressor Cell Ferroptosis and Enhances Cancer Therapy
by: Nada Mohamady Farouk Abdalsalam, et al.
Published: (2024-11-01)

SUBTYPE CHARACTERICS OF DENDRITIC CELLS FROM PERIPHERAL BLOOD OF PATIENTS WITH RHEUMATOID ARTHRITIS
by: S. A. Falaleeva, et al.
Published: (2014-07-01)

Myeloid‐Derived Suppressor Cells in Cancer: Mechanistic Insights and Targeted Therapeutic Innovations
by: Tianying Hu, et al.
Published: (2025-06-01)

Adult onset wilms tumor
by: Madhangi Parameswaran, MBBS, et al.
Published: (2025-03-01)

Effect of pregnancy-specific β1-glycoprotein on myeloid-derived suppressor cell differentiation
by: V. P. Timganova, et al.
Published: (2023-06-01)

Myeloid-derived suppressor cells prevent disruption of the gut barrier, preserve microbiota composition, and potentiate immunoregulatory pathways in a rat model of experimental autoimmune encephalomyelitis
by: Dušan Radojević, et al.
Published: (2022-12-01)

Significance of myeloid-derived suppressor cells (MDSCs) like CD14+B7-H4 cells frequency in blood and tumor microcirculation of lung cancer patients
by: Vuković Jelena, et al.
Published: (2021-01-01)

Transcriptional regulatory logic orchestrating lymphoid and myeloid cell fate decisions
by: Rasoul Godini, et al.
Published: (2025-05-01)

EVA1B facilitates esophageal squamous carcinoma progression and recruitment of immunosuppressive myeloid-derived suppressor cells in the tumor microenvironment
by: Tian Xia, et al.
Published: (2024-12-01)